Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Scilex Holding Company ( (SCLX) ) has provided an update.
On September 22, 2025, Scilex Holding Company experienced changes in its board of directors due to a business combination involving Denali Capital Acquisition Corp. and Semnur Pharmaceuticals, a majority-owned subsidiary of Scilex. Directors Annu Navani and Jaisim Shah resigned, with Mr. Shah’s affiliated company, Inform LLC, entering a consulting agreement with Scilex for five years. The board reduced its size from six to five members and appointed Stephen Ma, the company’s CFO, to fill the vacancy. These changes reflect strategic adjustments following the business combination, potentially impacting the company’s governance and operational dynamics.
The most recent analyst rating on (SCLX) stock is a Buy with a $770.00 price target. To see the full list of analyst forecasts on Scilex Holding Company stock, see the SCLX Stock Forecast page.
More about Scilex Holding Company
Average Trading Volume: 233,494
Technical Sentiment Signal: Buy
Current Market Cap: $198.9M
See more data about SCLX stock on TipRanks’ Stock Analysis page.